US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Antibody Technologies Market Research Reports & Industry Analysis

RSS Feeds

Antibody Technologies Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Anti-CD22 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and ...  |  read more...
USD 1,250
Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and ...  |  read more...
USD 1,250
Anti-CD28 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD33 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD38 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD4 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD52 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD80 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CS1 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
T-cell Immunotherapy: Clinical Trial Tracker
7/11/2016 | published by: Roots Analysis
... promising therapeutic strategies, developed under the banner of T-cell immunotherapies, are set to hit the market in the near future. T-cells, also named as the soldiers of the immune system, are featured with specificity and ...  |  read more...
USD 949
Anti-CD19 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD25 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD3 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD30 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD37 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD40 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD6 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD70 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-CD95 Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & ...  |  read more...
USD 1,250
Anti-Dickkopf-1 (Dkk-1) Antibody -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and ...  |  read more...
USD 1,250
Aurora A Kinase Inhibitors -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, ...  |  read more...
USD 1,250
Conference Documentation: Immunogenicity
6/14/2016 | published by: SMI Publishing, Ltd
... -3 times as fast as chemical entities.* The challenges for the biopharmaceutical market are different to those from traditional chemical entities. Immunogenicity continues to be a major concern for the field of science, due to ...  |  read more...
USD 788.78
Global Recombinant Protein Industry 2016 Market Research Report
5/30/2016 | published by: 9Dimen Research
... Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Recombinant Protein basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost ...  |  read more...
USD 2,850
Monoclonal Antibody Markets in China
5/1/2016 | published by: Asia Market Information & Development Company
... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic ...  |  read more...
USD 4,000
< prev 1    3  4  5  6  7  8  9  10